+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Evaluation of a new real-time blood continuous glucose monitoring system in pregnant women without gestational diabetes. A pilot study

Evaluation of a new real-time blood continuous glucose monitoring system in pregnant women without gestational diabetes. A pilot study

Journal of Perinatal and Neonatal Nursing 18(2): 93-102

The incidence of gestational diabetes mellitus (GDM) has reached epidemic proportions in the United States, affecting 200,000 pregnant women annually. Controversies exist regarding whether the glucose levels used to diagnose GDM in pregnancy should be lowered since similar fetal complications are seen in women with GDM as well as in nondiabetic women. Although GDM has been extensively studied, the effects of the earlier stage of glucose intolerance are not well understood. The objectives of this descriptive, comparative, correlational pilot study include assessment of real-time blood glucose concentrations in women (20) with idiopathic macrosomia and/or polyhydramnios but with a normal baseline glucose screening test. This group was compared to pregnant women (20) without idiopathic macrosomia and/or polyhydromnios as confirmed by normal ultrasounds (controls). All subjects had a normal screeing test and/or a 3-hour Glucose Tolerance Test earlier in the pregnancy and wore a continuous glucose monitoring system for 72 hours. No adverse maternal complications were seen. Neonatal complications included macrosomia, shoulder dystocia, and hyperbilirubinemia. There was no significant association between real-time blood glucose levels and adverse maternal or fetal/neonatal complications. There is little evidence available regarding real-time physiologic glycemic levels in pregnant women. The findings of our pilot study provide baseline data for the design of a larger study to compare blood glucose levels and complications in euglycemic women and compare to women with those impaired glucose tolerance.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 048993713

Download citation: RISBibTeXText

PMID: 15214248

Related references

Introductory experience with the continuous glucose monitoring system (CGMS; Medtronic Minimed) in detecting hyperglycemia by comparing the self-monitoring of blood glucose (SMBG) in non-pregnant women and in pregnant women with impaired glucose tolerance and gestational diabetes. Experimental and Clinical Endocrinology and Diabetes 112(10): 556-560, 2004

Evaluation of metabolic control in women with gestational diabetes mellitus by the continuous glucose monitoring system: a pilot study. Endocrine Practice 12(3): 245-250, 2006

Use of a real time continuous glucose monitoring system as an educational tool for patients with gestational diabetes. Diabetology and Metabolic Syndrome 8: 48, 2016

The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial. Diabetes Care 36(7): 1877-1883, 2013

Real-time continuous glucose monitoring improves glycaemic variability and neonatal outcomes in pregnant women with type 1 diabetes. BmjEvidence-BasedMedicine2018:, 2018

Maternal and perinatal outcomes in pregnant women with type 1 diabetes treated with continuous subcutaneous insulin infusion and real time continuous glucose monitoring in two specialized centers in Medellin, Colombia. Journal of Maternal-Fetal and Neonatal Medicine 31(6): 696-700, 2018

Comparison of the hyperglycemia detection between the self monitoring of blood glucose and continuous blood glucose measurement system ; Minimed in gestational diabetic and non-diabetic pregnant women. Diabetes 50(Suppl. 2): A382, 2001

Real-time continuous glucose monitoring as a tool to prevent severe hypoglycaemia in selected pregnant women with Type 1 diabetes - an observational study. Diabetic Medicine 31(3): 352-356, 2014

Analysis of Continuous Glucose Monitoring in Pregnant Women With Diabetes: Distinct Temporal Patterns of Glucose Associated With Large-for-Gestational-Age Infants. Diabetes Care 38(7): 1319-1325, 2015

Real-Time Continuous Glucose Monitoring in Gestational Diabetes: A Randomized Controlled Trial. American Journal of Perinatology 36(9): 891-897, 2019

Efficacy of continuous real-time blood glucose monitoring during and after prolonged high-intensity cycling exercise: spinning with a continuous glucose monitoring system. Diabetes Technology and Therapeutics 8(6): 627-635, 2006

Optimal timing for postprandial glucose measurement in pregnant women with diabetes and a non-diabetic pregnant population evaluated by the Continuous Glucose Monitoring System (CGMS). Journal of Perinatal Medicine 33(2): 125-131, 2005

Cost-effectiveness analysis of real-time continuous monitoring glucose compared to self-monitoring of blood glucose for diabetes mellitus in Spain. Journal of Evaluation in Clinical Practice 24(4): 772-781, 2018

First experiences with the continuous real-time glucose monitoring system (Guardian REAL-time CGMS) in a cat with diabetes mellitus. Schweizer Archiv für Tierheilkunde 151(1): 27-30, 2009

Use of real-time continuous glucose monitoring versus traditional self-monitoring of blood glucose levels improves glycaemic control in patients with type 1 diabetes. Evidence-Based Nursing 15(1): 7-8, 2012